We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for lutetium-177 non-carrier added supplied as 177LuCl3 (ANSTO t/a ANSTO Health)
Active ingredients
lutetium-177 non-carrier added supplied as 177LuCl3
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Indication
For the treatment of neuroendocrine tumours